Denali Therapeutics Inc. Shares Outstanding
Denali Therapeutics Inc. (DNLI) had Shares Outstanding of 159.76 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-06
- 2026-06-30: Shares outstanding (split-adjusted) 159.76M shares; Shares authorized (split-adjusted) 400.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 158.66M shares; Shares authorized (split-adjusted) 400.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 156.18M shares; Shares authorized (split-adjusted) 400.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 146.63M shares; Shares authorized (split-adjusted) 400.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 159.76M shares 10-Q · filed 2026-08-06 | 400.00M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 158.66M shares 10-Q · filed 2026-05-07 | 400.00M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 156.18M shares 10-Q · filed 2026-08-06 | 400.00M shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 146.63M shares 10-Q · filed 2025-11-06 | 400.00M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 145.69M shares 10-Q · filed 2025-08-11 | 400.00M shares 10-Q · filed 2025-08-11 |
| 2025-03-31 | 145.25M shares 10-Q · filed 2025-05-06 | 400.00M shares 10-Q · filed 2025-05-06 |
| 2024-12-31 | 144.22M shares 10-K · filed 2026-02-26 | 400.00M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 143.84M shares 10-Q · filed 2024-11-06 | 400.00M shares 10-Q · filed 2024-11-06 |
| 2024-06-30 | 143.12M shares 10-Q · filed 2024-08-01 | 400.00M shares 10-Q · filed 2024-08-01 |
| 2024-03-31 | 142.51M shares 10-Q · filed 2024-05-07 | 400.00M shares 10-Q · filed 2024-05-07 |
| 2023-12-31 | 138.39M shares 10-K · filed 2025-02-27 | 400.00M shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 138.05M shares 10-Q · filed 2023-11-07 | 400.00M shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 137.36M shares 10-Q · filed 2023-08-08 | 400.00M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 136.74M shares 10-Q · filed 2023-05-08 | 400.00M shares 10-Q · filed 2023-05-08 |
| 2022-12-31 | 135.97M shares 10-K · filed 2024-02-28 | 400.00M shares 10-K · filed 2024-02-28 |
| 2022-09-30 | 123.80M shares 10-Q · filed 2022-11-03 | 400.00M shares 10-Q · filed 2022-11-03 |
| 2022-06-30 | 123.16M shares 10-Q · filed 2022-08-08 | 400.00M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 122.86M shares 10-Q · filed 2022-05-05 | 400.00M shares 10-Q · filed 2022-05-05 |
| 2021-12-31 | 122.28M shares 10-K · filed 2023-02-27 | 400.00M shares 10-K · filed 2023-02-27 |
| 2021-09-30 | 122.01M shares 10-Q · filed 2021-11-04 | 400.00M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 121.53M shares 10-Q · filed 2021-08-04 | 400.00M shares 10-Q · filed 2021-08-04 |
| 2021-03-31 | 121.15M shares 10-Q · filed 2021-05-05 | 400.00M shares 10-Q · filed 2021-05-05 |
| 2020-12-31 | 120.53M shares 10-K · filed 2022-02-28 | 400.00M shares 10-K · filed 2022-02-28 |
| 2020-09-30 | 119.80M shares 10-Q · filed 2020-11-05 | 400.00M shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 105.90M shares 10-Q · filed 2020-08-07 | 400.00M shares 10-Q · filed 2020-08-07 |
| 2020-03-31 | 105.54M shares 10-Q · filed 2020-05-07 | 400.00M shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 96.19M shares 10-K · filed 2021-02-26 | 400.00M shares 10-K · filed 2021-02-26 |
| 2019-09-30 | 95.99M shares 10-Q · filed 2019-11-06 | 400.00M shares 10-Q · filed 2019-11-06 |
| 2019-06-30 | 95.66M shares 10-Q · filed 2019-08-06 | 400.00M shares 10-Q · filed 2019-08-06 |
| 2019-03-31 | 95.26M shares 10-Q · filed 2019-05-08 | 400.00M shares 10-Q · filed 2019-05-08 |
| 2018-12-31 | 94.66M shares 10-K · filed 2020-02-27 | 400.00M shares 10-K · filed 2020-02-27 |
| 2018-09-30 | 93.97M shares 10-Q · filed 2018-11-08 | 400.00M shares 10-Q · filed 2018-11-08 |
| 2018-06-30 | 93.32M shares 10-Q · filed 2018-08-09 | 400.00M shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 92.59M shares 10-Q · filed 2018-05-11 | 400.00M shares 10-Q · filed 2018-05-11 |
| 2017-12-31 | 87.48M shares 10-K · filed 2019-03-12 | 400.00M shares 10-K · filed 2019-03-12 |
| 2017-12-07 | (m) | 400.00M shares 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |